Katie Maurer, MD, PhD^1,2,3, Isabella N. Grabski, PhD^4*, Roch Houot, MD, PhD^5,6*, Satyen H Gohil^1,7*, Shogo Miura^1*, Robert A. Redd, MS^8*, Haoxiang Lyu, BS^1,9*, Wesley S Lu, BS^1,9*, Brodie Miles, PhD^10*, Mike Mattie, PhD^11*, Yohei Arihara, MD, PhD^1*, Mikaela M. McDonough, BS^12*, Carol Reynolds, PhD^12*, Michela Ansuinelli, MD^12*, Shuqiang Li, PhD^1,9*, Kenneth J. Livak, PhD^1,9*, Jerome Ritz, MD¹, Scott Rodig, MD, PhD¹³, Rafael A. Irizarry, PhD^4,14*, Philippe Armand, MD, PhD¹, Catherine J Wu, MD^1,2,3 and Caron A Jacobson, MD, MMSc¹²

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Harvard Medical School, Boston, MA
³Broad Institute of MIT and Harvard, Cambridge, MA
⁴Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA
⁵Centre Hospitalier Universitaire Rennes, Université de Rennes, Rennes Cedex, FRA
⁶CHU de Rennes, Rennes, France
⁷Haematology, University College Hospital, London, United Kingdom
⁸Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁹Translational Immunogenomics Lab, Dana-Farber Cancer Institute, Boston, MA
¹⁰Kite Pharma, a Gilead Company, Santa Monica, CA
¹¹Kite Pharma, a Gilead company, Santa Monica, CA
¹²Dana-Farber Cancer Institute, Boston, MA
¹³Department of Pathology, Brigham and Women's Hospital, Boston, MA
¹⁴Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA

Sandeep Raj, MD¹, Jin Xie, PhD^2*, Teng Fei, PhD^3*, Qinghua Song, PhD^2*, Jenny J. Kim, MD, MS², Christina To, MD², Marcel R.M. van den Brink⁴, Miguel-Angel Perales, MD⁵, Mike Mattie, PhD^2* and Roni Shouval, MD, PhD⁶

¹Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Kite Pharma, a Gilead company, Santa Monica, CA
³Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Lara Stepan, BS^1*, Sahar Ansari, PhD^1*, Abood Okal, PhD^2*, Justine Dell’Aringa, BS^1*, Ethan Thompson, PhD^1*, Alessandro Crotta, MD^3*, Victor A Chow, MD^1*, Jeremy S. Abramson, MD⁴, Manali Kamdar, MD^5*, Jacob J. Chabon^6*, Gregory Hogan, PhD^6*, David M. Kurtz, MD, PhD⁷, Ash A. Alizadeh, MD, PhD⁸ and Leanne Peiser, DPhil^1*

¹Bristol Myers Squibb, Seattle, WA
²Bristol Myers Squibb, Princeton, NJ
³Celgene, a Bristol-Myers Squibb Company, Boudry, Switzerland
⁴Massachusetts General Hospital Cancer Center, Boston, MA
⁵University of Colorado Cancer Center, Aurora, CO
⁶Foresight Diagnostics, Aurora, CO
⁷Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
⁸Stanford Cancer Institute, Stanford University, Stanford, CA

Mike Mattie, PhD^1*, Melanie Grosso^2*, Aurelie Auguste, PhD^2*, Denis Arnaud, MBA^2*, Frederick L. Locke, MD³, Sattva S. Neelapu, MD⁴, David B. Miklos, MD, PhD⁵, Caron A Jacobson, MD, MMSc⁶, Lazaros J. Lekakis^7*, Yi Lin, MD, PhD⁸, Armin Ghobadi, MD⁹, Jenny J. Kim, MD, MS¹, Jenny Nater^1*, Rhine R. Shen, PhD^10* and Jerome Galon^2,11*

¹Kite Pharma, a Gilead company, Santa Monica, CA
²Veracyte, Marseille, France
³Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
⁴Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA
⁶Dana-Farber Cancer Institute, Boston, MA
⁷Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL
⁸Mayo Clinic Cancer Center, Rochester, MN
⁹Division of Oncology, Washington University School of Medicine, Saint Louis, MO
¹⁰Kite, a Gilead Company, Santa Monica, CA
¹¹Universite de Paris, Centre de Recerche des Cordeliers, Equipe Labellisee Ligue Contre le Cancer, Laboratory of Integrative Cancer Immunology, INSERM, Sorbonne Universite, Paris, France

Gloria Iacoboni, MD^1*, Victor Navarro Garces^2*, Josu Iraola^1*, Pierre Sesques^3*, Kai Rejeski, MD⁴, Fabio Serpenti, MD^5*, Mariana Bastos-Oreiro^6*, ANA Africa Martin Lopez, MD^7*, Javier Delgado, MD^8*, Ariadna Perez^9*, Manuel Guerreiro, MD^10*, Ana Carolina Caballero Gonzalez^11*, Nuria Martinez-Cibrian, MD^12*, Hugo Daniel Luzardo Henriquez, MD^13*, Jose Maria Sanchez Pina^14*, Juan-Manuel Sancho, MD, PhD^15*, Herve Ghesquieres, MD^3*, Alberto Mussetti, MD^16*, Pere Barba, MD¹, Lucia Lopez Corral, MD, PhD^7*, Rafael Hernani^9*, Juan Luis Reguera, MD^8*, Anna Maria Sureda Balari, MD, PhD¹⁶, Francesc Bosch, MD, PhD^1*, Alejandro Martin Garcia-Sancho, MD^7*, Mi Kwon¹⁷, Andrea Kuhnl^5*, Marion Subklewe, MD⁴, Emmanuel Bachy, MD, PhD^18*, Guillermo Villacampa^19* and Pau Abrisqueta Costa^1*

¹Vall d'Hebron University Hospital, Barcelona, Spain
²Oncology Data Science (ODysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
³Lyon Sud Hospital, Lyon, France
⁴LMU University Hospital, Munich, Germany
⁵King’s College Hospital NHS Foundation Trust, London, United Kingdom
⁶Hospital General Universitario Gregorio Marañón, Madrid, Spain
⁷Hospital Universitario de Salamanca, Salamanca, Spain
⁸University Hospital Virgen del Rocío, Sevilla, Spain
⁹Hospital Clínico Universitario, Valencia, Spain
¹⁰Hospital Universitario La Fe, Valencia, Spain
¹¹Hematology Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain
¹²Hospital Clinic Barcelona, Barcelona, Spain
¹³Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
¹⁴Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
¹⁵Hematology Department, ICO Badalona, Germans Trias i Pujol University Hospital. Universitat Autònoma de Barcelona. Josep Carreras Leukemia Research Institute, Barcelona, Spain
¹⁶Hospital Duran i Reynals (Institut Català d'Oncologia), Hospitalet de Llobregat, Barcelona, Spain
¹⁷General University Hospital Gregorio Marañón, Madrid, Spain
¹⁸Hematology Department, Lyon Sud Hospital, Pierre-Bénite, France
¹⁹Oncology Data Science Group, Vall D'Hebron Institute of Oncology. Barcelona, Spa, Barcelona, Spain

Gloria Iacoboni, MD^1*, Gilles Crochet, MD^2*, Audrey Couturier, MD^3*, Emmanuel Bachy, MD, PhD^4*, Josu Iraola^1*, Thomas Gastinne, MD^5*, Charles Herbaux, MD, PhD^6*, Tom Fradon^7*, Mi Kwon⁸, Romain Gounot^9*, Nuria Martinez-Cibrian, MD^10*, Cristina Castilla-Llorente, MD^11*, Manuel Guerreiro, MD^12*, Clementine Sarkozy^13*, Jose Aspa-Cilleruelo^1*, Vincent Camus, MD^14*, Stephanie Guidez^15*, Adrien Chauchet^16*, Eric Deconinck¹⁶, Krimo Bouabdallah, MD^17*, Pere Barba, MD¹, Roch Houot, MD, PhD^3* and Franck Morschhauser¹⁸

¹Vall d'Hebron University Hospital, Barcelona, Spain
²Hematology Department, CHU UCL Namur, Yvoir, Belgium
³CHU de Rennes, Rennes, France
⁴Hematology Department, Lyon Sud Hospital, Pierre-Bénite, France
⁵Hématologie, Hôpital Hôtel Dieu, Nantes Cedex 1, France
⁶Clinical Hematology Department, Montpellier University Hospital, MONTPELLIER, France
⁷LYSARC, Lyon, France
⁸General University Hospital Gregorio Marañón, Madrid, Spain
⁹Lymphoid Malignancies Unit, HôPital Universitaire Henri Mondor, Assistanc, CréTeil, FRA
¹⁰Hospital Clinic Barcelona, Barcelona, Spain
¹¹Department of Hematology, Gustave Roussy Cancer Campus, Villejuif, France
¹²Hospital Universitario La Fe, Valencia, Spain
¹³Hematology department, Institut Curie, Saint Cloud, France
¹⁴Department of Hematology, Centre Henri Becquerel, Rouen, France
¹⁵Hematolgy department, University Hospital of Poitiers, Poitiers, France
¹⁶Besançon University Hospital, Besançon, France
¹⁷CHU Bordeaux Pessac, Bordeaux, FRA
¹⁸University of Lille, Centre Hospitalier Universitaire de Lille, Lille, AL, France